Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7716)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2024 (publication date) through Nov 27, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Emad-Eldin M, Balata GF, Elshorbagy EA, Hamed MS, Attia MS. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges. World J Diabetes 2024; 15(5): 828-852 [PMID: 38766443 DOI: 10.4239/wjd.v15.i5.828] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Emad-Eldin M, Balata GF, Elshorbagy EA, Hamed MS, Attia MS. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges. World J Diabetes 2024; 15(5): 828-852 [PMID: 38766443 DOI: 10.4239/wjd.v15.i5.828] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i5/828.htm |
| Number | Citing Articles |
| 1 |
Qingyun Cai, Peiyi Zhao, Xinda Chen, Shuyi Yu, Lixin Guo, Qi Pan. New Technologies for Blood Glucose Management in Elderly Diabetics: An Interpretation of the Guidelines for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition). AGING MEDICINE 2025; 8(5): 468 doi: 10.1002/agm2.70044
|
| 2 |
Mengyang Liu, Darren Svirskis, Thomas Proft, Jacelyn Loh, Naibo Yin, Hao Li, Danhui Li, Yongzhi Zhou, Shuo Chen, Lizhuo Song, Guanyu Chen, Wei-Yue Lu, Zhiwen Zhang, Zhou Zhou, Lian Li, Yuan Huang, Craig Bunt, Guiju Sun, Paul W.R. Harris, Margaret A. Brimble, Jingyuan Wen. Progress in peptide and protein therapeutics: Challenges and strategies. Acta Pharmaceutica Sinica B 2025; doi: 10.1016/j.apsb.2025.10.026
|
| 3 |
Ramzi Shawahna, Subhi Abu Hamad, Mohamad Egbaria, Hatim Hijaz, Iyad Maqboul, Mohammad Jaber. Inconvenience, lifestyle flexibility, glycemic control, and satisfaction with insulin treatment among patients with diabetes mellitus in palestine: a cross-sectional study. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-15564-x
|
| 4 |
Tran Ha Nguyen, Amanda Barefield, Lindsay Chandler, Gianluca De Leo. Self-Management Practices Among Adults With Diabetes in the United States: An Analysis of the 2017-2020 National Health and Nutrition Examination Survey (NHANES). The Science of Diabetes Self-Management and Care 2025; 51(1): 9 doi: 10.1177/26350106241306075
|
| 5 |
Tauseef Ullah Shah, Talha Masood, M Hassaan Shah, Sibte Abbas, Fatima Tu Zuhra , Iqra Khalil, Muhammad Hamza Ghufran, Hamza Usman, Sundas Safdar, Sheema Iqbal, Naqeeb Ullah. A Longitudinal Multicenter Study Comparing the Effectiveness of Pharmacological and Lifestyle-Only Interventions in Adults With Prediabetes for Preventing Acute Hyperglycemic Crises and Progression to Type 2 Diabetes Mellitus. Cureus 2025; doi: 10.7759/cureus.95420
|
| 6 |
Yuntao Liu, Changtong Li, Xiaozhou Feng, Tongtong Dang. Dynamic modeling of the Insulin-Glucose-Glucocorticoid impulsive control system. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-83326-2
|
| 7 |
Yiming Meng, Jing Sun, Yushu Ma, Cuicui Kong. Exo-hydrogel therapy: a revolutionary approach to managing diabetic complications. Journal of Nanobiotechnology 2025; 23(1) doi: 10.1186/s12951-025-03621-6
|
| 8 |
Francesco Giorgino, Zoltán Taybani, Alice Cheng, Amar Tebaibia, İnan Anaforoglu, Felipe Lauand, Soraly Servera, Xuan Li, Vivian Fonseca. A real-world study assessing the efficacy and safety of switching from basal bolus insulin therapy to once daily iGlarLixi in people with type 2 diabetes mellitus: soli de-escalation. Diabetes Research and Clinical Practice 2025; 229: 112945 doi: 10.1016/j.diabres.2025.112945
|